Drug recall D-1093-2022
Product
Prazosin Hydrochloride Capsules, USP, 1 mg, 100-count bottle, Rx only, MFG: Mylan Pharma, NDC 0378-1101-01
Reason for recall
cGMP deviations: Temperature abuse
Lots and codes
McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Recall details
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
- Quantity
- 8 bottles/100 tablets each
- Distribution
- USA nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- April 13, 2022
- Terminated
- November 30, 2023
Related products
- Prazosin Hydrochloride – drug information
- NDC 0378-2302 Prazosin Hydrochloride · Prazosin Hydrochloride 2 mg/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-1101 Prazosin Hydrochloride · Prazosin Hydrochloride 1 mg/1 · Mylan Pharmaceuticals Inc.
- NDC 0378-3205 Prazosin Hydrochloride · Prazosin Hydrochloride 5 mg/1 · Mylan Pharmaceuticals Inc.